LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Zoetis Inc

Zoetis Inc

Suletud

Sektor Tervishoid

189.59 1.82

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

188.85

Max

190.41

Põhinäitajad
By Trading Economics
Sissetulek	25M 624M
Müük	160M 2.4B
P/E Sektori keskmine	33.4 103.001
Aktsiakasum	1.56
Kasumimarginaal	26.441
Töötajad	14,100
EBITDA	35M 966M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+15.15 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	31. okt 2024
Järgmine dividendimakse kuupäev	29. nov 2024
Järgmine aktsia dividendi kuupäev (ex-date)	29. okt 2024

Turustatistika
By TradingEconomics
Turukapital	84B
Eelmine avamishind	187.77
Eelmine sulgemishind	189.59

Uudiste sentiment

By Acuity

34%

66%

285 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

182.9381 / N/A Toetus ja vastupanu

Zoetis Inc Graafik

Seotud uudised

6. aug 2024, 11:52 UTC

Tulu

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

29. apr 2024, 10:57 UTC

Omandamised, ülevõtmised, äriostud

Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million

12. apr 2024, 11:47 UTC

Suurimad hinnamuutused turgudel

Zoetis Shares Slip Premarket After WSJ Report on Arthritis Drugs for Pets

13. veebr 2024, 12:36 UTC

Tulu

Zoetis 4Q Net Up 14%, Sees 2024 Growth on Strong Pet, Livestock Demand

6. aug 2024, 11:44 UTC

Tulu

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6. aug 2024, 11:09 UTC

Tulu

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6. aug 2024, 11:08 UTC

Tulu

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6. aug 2024, 11:08 UTC

Tulu

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6. aug 2024, 11:08 UTC

Tulu

Zoetis 2Q Adj EPS $1.56 >ZTS

6. aug 2024, 11:00 UTC

Tulu

Zoetis 2Q Net $624M >ZTS

6. aug 2024, 11:00 UTC

Tulu

Zoetis 2Q Rev $2.36B >ZTS

6. aug 2024, 11:00 UTC

Tulu

Zoetis 2Q EPS $1.37 >ZTS

2. mai 2024, 17:43 UTC

Tulu

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2. mai 2024, 13:06 UTC

Tulu

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2. mai 2024, 11:27 UTC

Tulu

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2. mai 2024, 11:00 UTC

Tulu

Zoetis 1Q Net $599M >ZTS

2. mai 2024, 11:00 UTC

Tulu

Zoetis 1Q EPS $1.31 >ZTS

2. mai 2024, 11:00 UTC

Tulu

Zoetis 1Q Rev $2.19B >ZTS

12. apr 2024, 20:37 UTC

Tulu

These Stocks Moved the Most Today: JPMorgan Chase, Citigroup, AMD, Intel, Arista Networks, Zoetis, and More -- Barrons.com

13. veebr 2024, 12:02 UTC

Tulu

Zoetis Sees 2024 Adj EPS $5.74-Adj EPS $5.84 >ZTS

13. veebr 2024, 12:02 UTC

Tulu

Zoetis Sees 2024 EPS $5.34-EPS $5.44 >ZTS

13. veebr 2024, 12:01 UTC

Tulu

Zoetis Sees 2024 Net $2.468B-Net $2.513B >ZTS

13. veebr 2024, 12:01 UTC

Tulu

Zoetis Sees 2024 Rev $9.075B-$9.225B >ZTS

13. veebr 2024, 12:00 UTC

Tulu

Zoetis 4Q EPS $1.14 >ZTS

13. veebr 2024, 12:00 UTC

Tulu

Zoetis 4Q Rev $2.21B >ZTS

13. veebr 2024, 12:00 UTC

Tulu

Zoetis 4Q Net $525M >ZTS

2. nov 2023, 11:08 UTC

Tulu

Zoetis Updates FY23 EPS Guidance Due to Impact of Foreign Exchange Rates >ZTS

2. nov 2023, 11:08 UTC

Tulu

Zoetis Sees FY23 Adj EPS $5.38-Adj EPS $5.43 >ZTS

2. nov 2023, 11:08 UTC

Tulu

Zoetis Sees FY23 EPS $5.14-EPS $5.21 >ZTS

2. nov 2023, 11:07 UTC

Tulu

Zoetis Sees FY23 Net $2.38B-Net $2.415B >ZTS

Võrdlus sarnastega

Hinnamuutus

Zoetis Inc Prognoos

Hinnasiht

By TipRanks

15.15% tõus

12 kuu keskmine prognoos

Keskmine 217.9 USD 15.15%

Kõrge 248 USD

Madal 200 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Zoetis Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

Osta

Hoia

Müü

Põhineb 10 analüütiku instrumendi Zoetis Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

182.9381 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

285 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Zoetis Inc

Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.